Literature DB >> 11502885

Identification of potent and selective neuropeptide Y Y(1) receptor agonists with orexigenic activity in vivo.

D Mullins1, D Kirby, J Hwa, M Guzzi, J Rivier, E Parker.   

Abstract

Neuropeptide Y (NPY) binds to a family of G-protein coupled receptors termed Y(1), Y(2), Y(3), Y(4), Y(5), and y(6). The use of various receptor subtype-selective agonists and antagonists has facilitated identification of the receptor subtypes responsible for mediating many of the biological effects of NPY. For example, the potent orexigenic activity of NPY is believed to be mediated by both the Y(1) and Y(5) receptor subtypes. Several selective Y(5) receptor agonists that stimulate food intake in rodents are available, but no selective Y(1) receptor agonist has been reported. We have identified several NPY analogs that bind the NPY Y(1) receptor with high affinity and exhibit full agonist activity, measured as inhibition of forskolin-stimulated cAMP production in cells expressing the cloned NPY Y(1) receptor. [D-Arg(25)]-NPY, [D-His(26)]-NPY, Des-AA(10--17)[Cys(7,21),Pro(34)]-NPY, Des-AA(11--18)[Cys(7,21),D-Lys(9)(Ac)]-NPY, Des-AA(11--18)[Cys(7,21),D-Lys(9)(Ac),Pro(34)]-NPY, Des-AA(11--18)[Cys(7,21),D-Lys(9)(Ac),D-His(26)]-NPY and Des-AA(11--18)[Cys(7,21),D-Lys(9)(Ac),D-His(26), Pro(34)]-NPY bind the NPY Y(1) receptor with K(i) values of 0.9 +/- 0.2, 2.0 +/- 0.3, 0.2 +/- 0.05, 0.7 +/- 0.1, 0.2 +/- 0.01, 2.2 +/- 0.3, and 1.2 +/- 0.3 nM, respectively, and inhibit forskolin-stimulated cAMP production with EC(50) values of 0.2 +/- 0.02, 0.5 +/- 0.04, 0.3 +/- 0.03, 0.5 +/- 0.05, 0.4 +/- 0.16, 5.3 +/- 0.32, and 5.1 +/- 0.97 nM, respectively. These peptides are highly selective for the NPY Y(1) receptor relative to the NPY Y(2), Y(4), and Y(5) receptors. [D-Arg(25)]-NPY, [D-His(26)]-NPY and Des-AA(11--18)[Cys(7,21), D-Lys(9)(Ac),D-His(26),Pro(34)]-NPY stimulate food intake dose-responsively in Long-Evans rats for at least 4 h after intracerebroventricular administration. Although the involvement of Y(1) receptors in several physiological activities, such as vasoconstriction and anxiolysis, remains to be investigated, adequate tools are now available.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11502885

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  14 in total

1.  Agonists for neuropeptide Y receptors Y1 and Y5 stimulate different phases of feeding in guinea pigs.

Authors:  Anne Lecklin; Ingrid Lundell; Suvi Salmela; Pekka T Männistö; Annette G Beck-Sickinger; Dan Larhammar
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

Review 2.  Tobacco addiction and the dysregulation of brain stress systems.

Authors:  Adrie W Bruijnzeel
Journal:  Neurosci Biobehav Rev       Date:  2012-03-03       Impact factor: 8.989

3.  Effects of NPY and the specific Y1 receptor agonist [D-His(26)]-NPY on the deficit in brain reward function and somatic signs associated with nicotine withdrawal in rats.

Authors:  Daria Rylkova; Jeffrey Boissoneault; Shani Isaac; Melissa Prado; Hina P Shah; Adrie W Bruijnzeel
Journal:  Neuropeptides       Date:  2008-05-12       Impact factor: 3.286

Review 4.  Neuropeptide Y in normal eating and in genetic and dietary-induced obesity.

Authors:  B Beck
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

5.  NPY receptors as potential targets for anti-obesity drug development.

Authors:  Ernie Yulyaningsih; Lei Zhang; Herbert Herzog; Amanda Sainsbury
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

6.  Central neuropeptide Y modulates binge-like ethanol drinking in C57BL/6J mice via Y1 and Y2 receptors.

Authors:  Angela M Sparrow; Emily G Lowery-Gionta; Kristen E Pleil; Chia Li; Gretchen M Sprow; Benjamin R Cox; Jennifer A Rinker; Ana M Jijon; José Peňa; Montserrat Navarro; Thomas L Kash; Todd E Thiele
Journal:  Neuropsychopharmacology       Date:  2012-01-04       Impact factor: 7.853

Review 7.  Mechanisms for AgRP neuron-mediated regulation of appetitive behaviors in rodents.

Authors:  M Alex Thomas; Bingzhong Xue
Journal:  Physiol Behav       Date:  2017-10-12

Review 8.  Cross-talk between reproduction and energy homeostasis: central impact of estrogens, leptin and kisspeptin signaling.

Authors:  Casey C Nestor; Martin J Kelly; Oline K Rønnekleiv
Journal:  Horm Mol Biol Clin Investig       Date:  2014-03

9.  Fear-reducing effects of intra-amygdala neuropeptide Y infusion in animal models of conditioned fear: an NPY Y1 receptor independent effect.

Authors:  Markus Fendt; Hugo Bürki; Stefan Imobersteg; Kurt Lingenhöhl; Kevin H McAllister; David Orain; Doncho P Uzunov; Frederique Chaperon
Journal:  Psychopharmacology (Berl)       Date:  2009-07-17       Impact factor: 4.530

10.  Neuropeptide Y inhibits hypocretin/orexin neurons by multiple presynaptic and postsynaptic mechanisms: tonic depression of the hypothalamic arousal system.

Authors:  Li-Ying Fu; Claudio Acuna-Goycolea; Anthony N van den Pol
Journal:  J Neurosci       Date:  2004-10-06       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.